|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| (11) | Number of the document | 2637690 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11839071.5 |
| Date of filing the European patent application | 2011-11-11 | |
| (97) | Date of publication of the European application | 2013-09-18 |
| (45) | Date of publication and mention of the grant of the patent | 2016-09-21 |
| (46) | Date of publication of the claims translation | 2016-10-25 |
| (86) | Number | PCT/US2011/060388 |
| Date | 2011-11-11 |
| (87) | Number | WO 2012/065072 |
| Date | 2012-05-18 |
| (30) | Number | Date | Country code |
| 413960 P | 2010-11-15 | US | |
| 412728 P | 2010-11-11 | US |
| (72) |
NEU, Michael, DE
TSCHOEPE, Markus, DE
WEBER, Carsten, DE
REDDEN, Laura, US
FRAUNHOFER, Wolfgang, US
GASTENS, Martin, DE
FEICK, Alexander, CH
PAULSON, Susan K., US
ZHU, Tong, US
|
| (73) |
AbbVie Biotechnology Ltd,
Clarendon House 2, Church Street, HM 11 Hamilton,
BM
|
| (74) |
Genė Ona SRUOGIENĖ,
UAB TARPINĖ, A.P.Kavoliuko g. 24-152, LT-04328 Vilnius,
LT
|
| (54) | Didelės koncentracijos anti-TNFalfa antikūno skystos kompozicijos |
| HIGH CONCENTRATION ANTI-TNFalpha ANTIBODY LIQUID FORMULATIONS |
| Payment date | Validity (years) | Amount | |
| 2016-12-02 | 6 | 208.50 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2017-08-12 |